Hemoglobin F: New targets, new path

Blood

Volumn 108, Issue 3, 2006, Pages 783-784

  Perrine, Susan P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F;

ALLELE; BETA THALASSEMIA; CELL FRACTIONATION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CHROMOSOME 6Q; DISEASE COURSE; DNA MODIFICATION; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE REPRESSION; GENE TARGETING; HEMOLYSIS; HUMAN; NOTE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; SICKLE CELL; SICKLE CELL ANEMIA; UPREGULATION;

EID: 33746582713     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-022582     Document Type: Note

References (4)

1. Steinberg, MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129:465-481.
2. Bunn HF. Induction of fetal hemoglobin in sickle cell disease. Blood. 1999;93:1787-1789.
3. Atweh GF, Sutton M, Nassif I, et al. Susatined induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 1999;93:1790-1797.
4. Perrine RP, Brown MJ, Clegg JB, Weatherall DJ, May A. Benign sickle cell anemia. Lancet. 1972;2:1163-1167.